Transcript 20020507-GovAffilHealth-Bove

FDA Participation
in the Internet2 Community
Celeste F. Bové, M.A., CCC-A
Senior Science Policy Analyst
Office of Science Coordination & Communication
Food and Drug Administration
May 7, 2002
FDA Organization
Center for Biologics Evaluation and Research
Center for Devices and Radiological Health
Center for Drug Evaluation and Research
Center for Food Safety and Applied Nutrition
Center for Veterinary Medicine
National Center for Toxicological Research
Office of Regulatory Affairs
Office of the Commissioner
2
FDA Regulatory Science Focus
Public health questions
Better tools and methods
New science, new technologies
Information management
Adeptness of scientific workforce
Consumer information
3
New Science - New Technologies
Genomics, proteomics
Tissue products
Robotics
Biosensors, drug delivery systems
Transgenics
4
Information Management
Informatics
Artificial intelligence tools
Knowledge/ data management
Computational science
Risk Management
5
FDA - A Scientific Agency
Training, retraining
Communication among scientists
6
Consumer Information
Freedom of choice, right to know
Risk communication
7
Internet2 - Current Status
 Ramp-up stage, i.e., disseminate information
across the agency
 Facilitate communication between and among
interested scientists
 Identify potential uses for Internet2
technology
 Identify regulatory implications
 Assess value to agency
8